BIOVETA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5272676754

KRS0000419615

Share capital5,000.00 zł

Not confirmed

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. CHORZOWSKA 150, 40-101 KATOWICE

Show on map

Activity type

manufacturer, service provider

Register Data

Full name

BIOVETA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. CHORZOWSKA 150, 40-101 KATOWICE

Show on map

NIP

5272676754

REGON

146108738

KRS

0000419615

Legal form

limited liability company

ALEO.com Registration Date

2022-03-29

Register Address

UL. CHORZOWSKA 150, 40-101 KATOWICE

Date of registration in KRS

2012-04-27

Date of commencement of economic activity

2012-04-27

Act signature

RDF/509299/23/321

Pkd codes

73.20.Z - Market research and public opinion polling

21.10.Z - Manufacture of basic pharmaceutical substances

21.20.Z - Manufacture of medicines and other pharmaceutical products

46.46.Z - Wholesale of pharmaceutical goods

52.10.B - Warehousing and storage of other goods

58.14.Z - Publishing of journals and periodicals

63.99.Z - Other information service activities not elsewhere classified

85.60.Z - Educational support activities

96.09.Z - Other personal service activities not elsewhere classified

Payer VAT status

Active

Vat list bank account(s)

PL84 1050 1214 1000 0090 3268 7775

PL62 1050 1214 1000 0090 3268 7783

PL40 1050 1214 1000 0090 3268 7791

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Marek Vystavel

Member Of The Board, 47 years old

Jaromir Saxl

Member Of The Board, 72 years old

shareholders

BIOVETA HOLDINGS A.S.

100% 100 udziałów o łącznej wysokości 5000,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2020	2021	2022
	M PLN	M PLN	M PLN	%
Net sales	1,1	1,2	1,2	2,3
Liabilities and provisions	0,2	0,2	0,3	35
Equity	0,2	0,1	0	-60
Total assets	0,4	0,3	0,3	2,8
Cash and cash equivalents	0,1	0,1	0,1	62,5
Depreciation	0	0	0	-30,6
Gross profit / loss	0,1	-0,1	-0,1	6,8
EBITDA	0,1	0	0	-30,2
Current assets	0,3	0,2	0,3	15,2
Operating profit (EBIT)	0,1	-0	-0	30,7
Net profit / loss	0,1	-0,1	-0,1	6,8
	%	%	%	p.p.
Return on equity (ROE)	46,7	-64,4	-150,2	-85,8
Return on sales (ROS)	7,4	-5,7	-5,2	0,5
Equity ratio	43,8	33,9	13,2	-20,7
EBITDA margin	12,9	0,3	0,2	-0,1
Gross profit margin	7,4	-5,7	-5,2	0,5
	Days	Days	Days	Days
Current liabilities turnover ratio	21	29	27	-2